Cancers | Free Full-Text | CD18 Antibody Application Blocks Unwanted Off-Target T Cell Activation Caused by Bispecific Antibodies
Switchable CAR-T Cells Outperformed Traditional Antibody-Redirected Therapeutics Targeting Breast Cancers | ACS Synthetic Biology
Frontiers | T-Cell Dependent Immunogenicity of Protein Therapeutics Pre-clinical Assessment and Mitigation–Updated Consensus and Review 2020
What is the role of T cells in COVID-19 infection? Why immunity is about more than antibodies - The Centre for Evidence-Based Medicine
Not just antibodies: B cells and T cells mediate immunity to COVID-19 | Nature Reviews Immunology
Overcoming the challenges associated with CD3+ T-cell redirection in cancer | British Journal of Cancer
JCI - Peripheral CD4+ T cell subsets and antibody response in COVID-19 convalescent individuals
Pharmaceuticals | Free Full-Text | T Cell Bispecific Antibodies: An Antibody-Based Delivery System for Inducing Antitumor Immunity
A Synchronous IRF4-Dependent Gene Regulatory Network in B and Helper T Cells Orchestrating the Antibody Response: Trends in Immunology
Antibodies | Free Full-Text | Bispecific T-Cell Redirection versus Chimeric Antigen Receptor (CAR)-T Cells as Approaches to Kill Cancer Cells
Antibodies | Free Full-Text | Natural Killer (NK)- and T-Cell Engaging Antibody-Derived Therapeutics
T-cell Bispecific Antibodies | Genentech Oncology
The landscape of bispecific T cell engager in cancer treatment | Biomarker Research | Full Text
Frontiers | γδ T Cells in the Tumor Microenvironment—Interactions With Other Immune Cells
Decrease in Antibodies Against SARS-CoV-2 Over Time and Current Role of Serological Testing - Ontario COVID-19 Science Advisory Table
Adaptive immunity and SARS-CoV-2
T cell activation - Antineo
Robust T cell and humoral immune response to SARS-CoV-2 in patients with immunodeficiency
The Biodistribution of a CD3 and EpCAM Bispecific T-Cell Engager Is Driven by the CD3 Arm | Journal of Nuclear Medicine
T Cell Immunity? | BioBus
Vaccines | Free Full-Text | B-Cell-Based Immunotherapy: A Promising New Alternative
Antibodies + CAR-T Cells - Gene Center Munich - LMU Munich
Frontiers | Engineering Immune Cells for in vivo Secretion of Tumor-Specific T Cell-Redirecting Bispecific Antibodies
Characterization and modulation of anti-αβTCR antibodies and their respective binding sites at the βTCR chain to enrich engineered T cells: Molecular Therapy - Methods & Clinical Development
The Search for Immune Responses that Stop COVID-19 | The Scientist Magazine®
Viral nucleoprotein antibodies activate TRIM21 and induce T cell immunity | The EMBO Journal
An Introduction to Antibodies: Antigens, Epitopes and Antibodies
More on T Cells, Antibody Levels, and Our Ignorance | Science | AAAS
